Dr. Carmelo M. Licitra, MD

Dr. Licitra practices at Arnold Palmer Hospital for Children in Orlando, Florida.

Dr. Licitra's NPI, 1659347342, was assigned on February 23, 2006. Dr. Licitra graduated from University Of Florida College Of Medicine in 1982. Dr. Licitra holds Florida license ME0042655.

Dr. Licitra's primary practice is Arnold Palmer Hospital for Children, at 92 W Miller St, Orlando, FL 32806 in Orange County. The practice phone is (407) 650-5028.

Dr. Licitra's primary practice is Arnold Palmer Hospital for Children in Orlando, Florida. Dr. Licitra is also affiliated with AdventHealth Orlando. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Licitra to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Licitra practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Licitra's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Licitra is board certified in infectious disease by the American Board of Internal Medicine. Dr. Licitra is licensed in Florida.

Dmand AI lists acute skin infection, bronchitis, hiv/aids, immune deficiency disease, joint or bone infection, pneumonia and UTI among the conditions Dr. Licitra treats.

CMS data shows 272 Medicare services from Dr. Licitra across 6 procedure codes in 2024, for 163 Medicare patients. Medicare paid $24,001 for them.

CMS counts 163 Medicare patients who saw Dr. Licitra in 2024. The largest group is 75 to 84, with 67 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Licitra's median patient age at 69, with 55% women.

In 2024, Dr. Licitra wrote 1,119 Medicare Part D claims for 182 patients. 52% of them were for generic drugs. CMS names the drug for 908 of them, across 26 drugs with 11 or more claims each, at $1,995,801 in total drug cost. In 2023, CMS named 874 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Licitra for performance year 2024, reported as part of a group. Dr. Licitra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Licitra as offering telehealth.

Dmand AI links 15 papers to Dr. Licitra, published from 2013 to 2024. 2013 was the busiest year, with 3. The most frequent topics are Bacteremia, Communicable Diseases and COVID-19. Dr. Licitra's most frequent co-authors are Davidson H. Hamer, MD, Kristina Marie Angelo, DO and Phyllis E. Kozarsky, MD.

CMS Open Payments shows 48 general payments to Dr. Licitra from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. ViiV Healthcare Company paid the most, $269.

Dmand AI lists 2 awards for Dr. Licitra, most recently Top Doctors: Florida in 2000.

Dr. Licitra graduated from University Of Florida College Of Medicine in 1982. Dr. Licitra is a member of ACP and International Society Travel Medicine.

Dr. Licitra is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.